Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00867477 · ClinicalTrials.gov registry record · Phase 2
PMRR-NO: Pulmonary Metabolic Radiation Response Versus Exhaled Nitric Oxide
A Phase 2 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 163
- Enrollment target
NCT00867477: Completed Phase 2 study, sponsored by M.D. Anderson Cancer Center.
NCT00867477 is a Phase 2 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 163 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (23% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00867477, a Phase 2 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 163 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to use a new breathing test that measures the amount of nitric oxide (NO) you exhale. Researchers want to compare your "NO" levels to the amount of inflammation in your lungs, as measured using a positron emission tomography (PET) scan reading, and with respiratory symptoms questionnaire.
Primary Outcome
Association between exhaled nitric oxide (NO) and PMRR (pulmonary metabolic radiation response). FDG-PET imaging (to determine PMRR) and exhaled NO assessed three times on same day of PET imaging.
Interventions
- PROCEDURE Pet Scan
- PROCEDURE Breathing Test
- BEHAVIORAL Respiratory Symptoms Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 163 participants |
| Start Date | 2009-03 |
| Est. Completion | 2014-08 |
| Phase | Phase 2 |
What the finished NCT00867477 record still lists
NCT00867477 is an interventional study that assigns participants to a tested intervention. The registered 163 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (23% higher).
The record links to 0 conditions, and to 3 interventions - of which Pet Scan is the first listed.
NCT00867477 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00867477 about?
NCT00867477 is a clinical study titled "PMRR-NO: Pulmonary Metabolic Radiation Response Versus Exhaled Nitric Oxide". The goal of this clinical research study is to use a new breathing test that measures the amount of nitric oxide (NO) you exhale. Researchers want to compare your "NO" levels to the amount of inflammation in your lungs, as measured using a positron emission tomography (PET) scan reading, and with re...
What is the current status of trial NCT00867477?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 163 participants. The study started on 2009-03. Estimated completion is 2014-08.
What interventions are being tested in trial NCT00867477?
The interventions under investigation include: Pet Scan (PROCEDURE), Breathing Test (PROCEDURE), Respiratory Symptoms Questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT00867477?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00867477's enrollment target sits among peer trials
163 418th of 2000 higher than 1,583 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03180268 · 163 participants · Phase 3
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
- NCT04862221 · 163 participants · Phase 2
TReatment for ImmUne Mediated PathopHysiology
- NCT05702229 · 163 participants · Phase 2
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
- NCT06137118 · 163 participants · Phase 1
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia